Viewing StudyNCT00135395



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00135395
Status: COMPLETED
Last Update Posted: 2010-02-05
First Post: 2005-08-25

Brief Title: A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-05
Start Date Type: None
Primary Completion Date: 2006-02
Primary Completion Date Type: ACTUAL
Completion Date: 2006-02
Completion Date Type: ACTUAL
First Submit Date: 2005-08-25
First Submit QC Date: August 25 2005
Study First Post Date: 2005-08-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2010-02-03
Disp First Submit QC Date: February 3 2010
Disp First Post Date: 2010-02-05
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2010-02-03
Last Update Post Date: 2010-02-05
Last Update Post Date Type: ESTIMATED